Trials / Completed
CompletedNCT02598167
Participants Preferences to Disease Modifying Agents in Relapsing Remitting Multiple Sclerosis Condition
Assessing Patients Preferences Towards Disease-modifying Therapeutic Options in Relapsing Remitting Multiple Sclerosis
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 223 (actual)
- Sponsor
- Hoffmann-La Roche · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This multi-center non-interventional, observational, cross-sectional study in adult participants with relapsing remitting multiple sclerosis (RRMS) will evaluate the participants' preferences for disease modifying treatments (DMT) in routine clinical practice.
Conditions
Timeline
- Start date
- 2015-12-07
- Primary completion
- 2016-02-23
- Completion
- 2016-02-23
- First posted
- 2015-11-05
- Last updated
- 2017-10-25
Locations
18 sites across 1 country: Spain
Source: ClinicalTrials.gov record NCT02598167. Inclusion in this directory is not an endorsement.